Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I bet the USPTO review is the reason for the stay

...given the depth of the replies by TPL and Moore as to prior art etc, the ruling may come sooner rather than later. If so, TPL would be aware of the direction that the USPTO is taking. There again, the requested stay might be for a completely different reason/s.

 

 

Be well

Share
New Message
Please login to post a reply